Form D · Biotechnology
Triad Life Sciences Inc.
Memphis, TN · CIK 0001721364
Offering snapshot reported Apr 21, 2020 · SEC filing
- Reported sold
- $6.59M Offering amount: $6.59M
- Investors reported
- 29 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Apr 6, 2020 As reported in this filing
Fundraising history
Reported soldDates are filing dates, not cash receipt dates. Decreases are reported revisions, not evidence of withdrawals. Separate offering histories are not added together.
What changed?
Latest filing versus its linked predecessor, where available.
- Reported sold$4,995,904 → $6,590,904
- Reported investors14 → 29
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Apr 21, 2020 | Initial | $4,995,904 | No comparison | 14 | SEC filing |
| Apr 21, 2020 | Amendment | $6,590,904 | $1,595,000vs Apr 21, 2020 | 29 | SEC filing |
| May 24, 2019 | Initial | $3,339,228 | No comparison | 3 | SEC filing |
| Mar 14, 2019 | Initial | $2,950,000 | No comparison | 6 | SEC filing |
| Jun 11, 2018 | Initial | $2,867,500 | No comparison | 2 | SEC filing |
| Mar 26, 2018 | Amendment | $1,310,000 | $310,000vs Nov 15, 2017 | 5 | SEC filing |
| Nov 15, 2017 | Initial | $1,000,000 | No comparison | 4 | SEC filing |
Offering details
- Securities
- Equity, Option to acquire, Security to be acquired
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $247K
- Finders' fees
- $0
- Form D file number
- 021-365472
Commissions include issuance of options
Sales compensation recipients
Scroll to see all columns →
| Recipient | CRD | Associated broker-dealer |
|---|---|---|
| Paulson Investment Company LLC | 5670 |
Source: Form D, filed Apr 21, 2020. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Donna Best | Director, Executive |
| Kevin Foley | Director |
| Kevin Foley, M.D. | Director |
| Kurt Klitzke | Executive |
| Ron Nixon | Director |
| Russell Olsen | Director, Executive |
| George White | Director, Executive |
Issuer details
Industry: Biotechnology (See others in industry)
Address:
1770 Moriah Woods Blvd. Suite 18
Memphis, TN, 38117
Memphis, TN, 38117